Neoadjuvant Therapy

Impact of adding bevacizumab to presurgery chemotherapy for triple-negative breast cancer varies

By

The addition of bevacizumab to standard presurgery chemotherapy showed greater benefit in those whose cancers were classified as basal-like by gene expression assay, compared with those whose cancers were nonbasal-like.

Neoadjuvant meds for HER2+ breast cancer

Neoadjuvant meds for HER2+ breast cancer

Approximately 25% to 30% of breast cancers are the result of the overexpression of the HER2 gene.

Preoperative/neoadjuvant therapy may benefit patients with initially unresectable pancreatic cancer

By

Patients with initially unresectable pancreatic cancer might experience clinical benefits from neoadjuvant therapy, according to a study published in PLoS Medicine (2010 Apr 20;7(4):e1000267).

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs